Correlation Between Molecular Partners and 828807DM6

Can any of the company-specific risk be diversified away by investing in both Molecular Partners and 828807DM6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and 828807DM6 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Molecular Partners AG and SPG 22 01 FEB 31, you can compare the effects of market volatilities on Molecular Partners and 828807DM6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of 828807DM6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and 828807DM6.

Diversification Opportunities for Molecular Partners and 828807DM6

-0.24

Correlation Coefficient

Molecular Partners  828807DM6

Very good diversification

The 3 months correlation between Molecular and 828807DM6 is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and SPG 22 01 FEB 31 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SPG 22 01 and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with 828807DM6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SPG 22 01 has no effect on the direction of Molecular Partners i.e., Molecular Partners and 828807DM6 go up and down completely randomly.

Pair Corralation between Molecular Partners and 828807DM6

Given the investment horizon of 90 days Molecular Partners AG is expected to generate 14.79 times more return on investment than 828807DM6. However, Molecular Partners is 14.79 times more volatile than SPG 22 01 FEB 31. It trades about 0.03 of its potential returns per unit of risk. SPG 22 01 FEB 31 is currently generating about 0.06 per unit of risk. If you would invest  420.00  in Molecular Partners AG on December 25, 2024 and sell it today you would lose (32.00) from holding Molecular Partners AG or give up 7.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.19%
Values	Daily Returns

Molecular Partners AG  vs.  SPG 22 01 FEB 31

Molecular Partners

Risk-Adjusted Performance

Very Weak

Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

SPG 22 01

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SPG 22 01 FEB 31 are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 828807DM6 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Molecular Partners and 828807DM6

The main advantage of trading using opposite Molecular Partners and 828807DM6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, 828807DM6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 828807DM6 will offset losses from the drop in 828807DM6's long position.

The idea behind Molecular Partners AG and SPG 22 01 FEB 31 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.